{"id":60039,"date":"2024-09-19T01:07:04","date_gmt":"2024-09-18T23:07:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/"},"modified":"2024-09-19T01:07:04","modified_gmt":"2024-09-18T23:07:04","slug":"axonics-prevails-in-patent-infringement-lawsuit-with-medtronic","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/","title":{"rendered":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic"},"content":{"rendered":"
\n

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe jury found that Axonics does not infringe any of the three patents-in-suit.\n<\/p>\n

\n\u201cA jury of our peers recognized that Axonics\u2019 proprietary tined lead design and temperature sensor technology is differentiated from our competitor\u2019s intellectual property,\u201d said Raymond W. Cohen, chief executive officer. \u201cAs we have said since this case was first filed in late 2019, our view is that Medtronic\u2019s lawsuit was initiated to stifle competition, limit patient and physician choice, and protect the incumbent\u2019s monopoly in sacral neuromodulation. We are very pleased with the jury\u2019s finding and continue to remain focused on fulfilling our mission of positively impacting the lives of adults with bladder and bowel dysfunction.\u201d\n<\/p>\n

\nAbout Axonics<\/b>\n<\/p>\n

\nAxonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics ranked No. 2 on the 2023<\/a> Financial Times ranking of the fastest growing companies in the Americas after being ranked No. 1 in 2022<\/a>.\n<\/p>\n

\nAxonics\u00ae<\/sup> sacral neuromodulation systems provide adults with overactive bladder and\/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company\u2019s best-in-class urethral bulking hydrogel, Bulkamid\u00ae<\/sup>, provides safe and durable symptom relief to women with stress urinary incontinence. In the U.S., moderate to severe urinary and bowel incontinence affects tens of millions of adults. For more information, visit www.axonics.com<\/a>.\n<\/p>\n

\nCautionary Statement Regarding Forward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words like \u201cmay,\u201d \u201cwill,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cfuture,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cgoal,\u201d \u201cseek,\u201d \u201cendeavor,\u201d \u201cestimate,\u201d \u201cproject,\u201d \u201ccontinue,\u201d and variations of such words and similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, assumptions, and uncertainties, including, but not limited to, risks related to: Axonics\u2019 ability to consummate the transactions contemplated by the Agreement and Plan of Merger, dated January 8, 2024 (the \u201cMerger Agreement\u201d), by and among Axonics, Boston Scientific Corporation (\u201cBoston Scientific\u201d), and Sadie Merger Sub, Inc., a wholly owned subsidiary of Boston Scientific (\u201cMerger Sub\u201d), providing for the merger of Merger Sub with and into Axonics with Axonics continuing as the surviving company and a wholly owned subsidiary of Boston Scientific (the \u201cMerger\u201d), in a timely manner or at all; the risk that the Merger Agreement may be terminated in circumstances requiring the payment by Axonics of a termination fee; the satisfaction (or waiver) of the conditions to the closing of the Merger; potential delays in consummating the Merger; the occurrence of any event, change or other circumstance or condition that could give rise to termination of the Merger Agreement; Axonics\u2019 ability to timely and successfully realize the anticipated benefits of the Merger; the ability to successfully integrate the businesses of Axonics and Boston Scientific; the effect of the announcement or pendency of the Merger on Axonics\u2019 current plans, business relationships, operating results and business generally; the effect of limitations placed on Axonics\u2019 business under the Merger Agreement; significant transaction costs and unknown liabilities; litigation or regulatory actions related to the Merger Agreement or Merger; FDA or other U.S. or foreign regulatory or legal actions or changes affecting Axonics or Axonics\u2019 industry; the results of any ongoing or future legal proceedings, including the litigation with Medtronic, Inc., Medtronic Puerto Rico Operations Co., Medtronic Logistics LLC and Medtronic USA, Inc. (the \u201cMedtronic Litigation\u201d); any termination or loss of intellectual property rights, including as a result of the Medtronic Litigation; introductions and announcements of new technologies by Axonics, any commercialization partners or Axonics\u2019 competitors, and the timing of these introductions and announcements; changes in macroeconomic and market conditions and volatility, including the risk of recession, inflation, supply chain constraints or disruptions and rising interest rates; and economic and market conditions in general and in the medical technology industry specifically, including the size and growth, if any, of Axonics\u2019 markets, and risks related to other factors described under \u201cRisk Factors\u201d in other reports and statements filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including Axonics\u2019 most recent Annual Report on Form 10-K, which is available on the investor relations section of Axonics\u2019 website at www.axonics.com<\/a> and on the SEC\u2019s website at www.sec.gov<\/a>. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.\n<\/p>\n

\nThe forward-looking statements included in this press release are made only as of the date of this press release, and except as otherwise required by federal securities law, Axonics does not assume any obligation nor does it intend to publicly update or revise any forward-looking statements to reflect new information, changed circumstances or unanticipated events.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAxonics contact<\/b>:
\n
Neil Bhalodkar
\n
IR@axonics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California. The jury found that Axonics does not infringe any of the three patents-in-suit. \u201cA jury of our peers recognized … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60039","6":"format-standard","7":"category-industry"},"yoast_head":"\nAxonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Axonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California. The jury found that Axonics does not infringe any of the three patents-in-suit. \u201cA jury of our peers recognized ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-18T23:07:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Axonics Prevails in Patent Infringement Lawsuit with Medtronic\",\"datePublished\":\"2024-09-18T23:07:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/\"},\"wordCount\":864,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240918852695\\\/en\\\/788134\\\/22\\\/Axonics_Logo_-_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/\",\"name\":\"Axonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240918852695\\\/en\\\/788134\\\/22\\\/Axonics_Logo_-_Color.jpg\",\"datePublished\":\"2024-09-18T23:07:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240918852695\\\/en\\\/788134\\\/22\\\/Axonics_Logo_-_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240918852695\\\/en\\\/788134\\\/22\\\/Axonics_Logo_-_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Axonics Prevails in Patent Infringement Lawsuit with Medtronic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/","og_locale":"en_US","og_type":"article","og_title":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend","og_description":"IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California. The jury found that Axonics does not infringe any of the three patents-in-suit. \u201cA jury of our peers recognized ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/","og_site_name":"Pharma Trend","article_published_time":"2024-09-18T23:07:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic","datePublished":"2024-09-18T23:07:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/"},"wordCount":864,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/","url":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/","name":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg","datePublished":"2024-09-18T23:07:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240918852695\/en\/788134\/22\/Axonics_Logo_-_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Axonics Prevails in Patent Infringement Lawsuit with Medtronic"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60039"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60039\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}